We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+4.81%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$6.76B
AUM Growth
-$242M
Cap. Flow
-$327M
Cap. Flow %
-4.84%
Top 10 Hldgs %
33.67%
Holding
152
New
46
Increased
32
Reduced
19
Closed
46

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$211M
2
MCD icon
McDonald's
MCD
+$204M
3
PSFE icon
Paysafe
PSFE
+$175M
4
MA icon
Mastercard
MA
+$166M
5
RH icon
RH
RH
+$154M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$237M
2
NFLX icon
Netflix
NFLX
+$208M
3
CHTR icon
Charter Communications
CHTR
+$190M
4
ATVI
Activision Blizzard
ATVI
+$184M
5
FISV
Fiserv Inc
FISV
+$182M

Sector Composition

Rank Sector Weight
1 Healthcare 23.59%
2 Consumer Discretionary 21.28%
3 Technology 20%
4 Industrials 14.28%
5 Communication Services 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMRX
76
DELISTED
Chimerix, Inc.
CMRX
$8.82M 0.13%
+915,264
New +$8.4M
KDNY
77
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$8.54M 0.13%
549,615
+23,160
+4% +$378K
KZR
78
DELISTED
Kezar Life Sciences
KZR
$8.4M 0.12%
140,996
– –
HRTX icon
79
Heron Therapeutics
HRTX
$92.9M
$8.2M 0.12%
+506,037
New +$9.02M
XENE icon
80
Xenon Pharmaceuticals
XENE
$6.12B
$7.88M 0.12%
+440,064
New +$7.46M
NHIC
81
DELISTED
NewHold Investment Corp. Class A Common Stock
NHIC
$7.51M 0.11%
+750,000
New +$7.76M
INZY
82
DELISTED
Inozyme Pharma
INZY
$6.76M 0.1%
341,427
+127,116
+59% +$2.8M
OTIC
83
DELISTED
Otonomy, Inc.
OTIC
$5.25M 0.08%
2,060,200
+1,437,500
+231% +$5.89M
RACB
84
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$5.13M 0.08%
+500,000
New +$5.12M
MIST icon
85
Milestone Pharmaceuticals
MIST
$152M
$4.93M 0.07%
851,291
– –
PRDS
86
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$3.98M 0.06%
+400,000
New +$4.14M
ADAG
87
Adagene
ADAG
$272M
$3.66M 0.05%
+204,000
New +$4.65M
EBACU
88
DELISTED
European Biotech Acquisition Corp. Units
EBACU
$3.02M 0.04%
+300,000
New +$3M
HCAQ
89
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$3M 0.04%
+300,000
New +$3.07M
DBTX
90
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$2.99M 0.04%
+263,600
New +$4.14M
OMEG
91
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$2.97M 0.04%
+300,000
New +$3.12M
JWS.WS
92
DELISTED
Jaws Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary
JWS.WS
$2.15M 0.03%
674,566
– –
BLSA
93
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$2.11M 0.03%
200,000
– –
TMPM
94
DELISTED
Turmeric Acquisition Corp. Class A Ordinary Shares
TMPM
$1.95M 0.03%
200,000
– –
DSEY
95
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$1.58M 0.02%
+107,301
New +$1.6M
WPF.WS
96
DELISTED
Foley Trasimene Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
WPF.WS
$1.24M 0.02%
774,375
– –
FHTX icon
97
Foghorn Therapeutics
FHTX
$360M
$1.11M 0.02%
84,000
-174,700
-68% -$2.86M
ARYD
98
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$1.05M 0.02%
+100,000
New +$1.08M
EUCR
99
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$998K 0.01%
99,999
– –
FLAC
100
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
$871K 0.01%
+87,498
New +$893K
2 3
4
5 6

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Suvretta Capital Management held 152 positions worth $6.76B, down 3.5% from $7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Suvretta Capital Management withdrew a net $327M in Q1 2021, closing 46 positions and reducing 19 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $237M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Suvretta Capital Management opened a new position in Walt Disney worth $212M.

  • Suvretta Capital Management's largest Q1 2021 buy was Walt Disney: 1,146,508 shares worth $212M.
  • Suvretta Capital Management added most to Uber in Q1 2021, an estimated $87.4M increase.
  • Suvretta Capital Management's biggest Q1 2021 reduction was Adobe, cutting an estimated $158M.
  • Suvretta Capital Management fully exited Meta Platforms (Facebook) in Q1 2021, selling an estimated $237M.
  • Suvretta Capital Management's ten largest holdings make up 34% of its $6.76B portfolio in Q1 2021.
  • Suvretta Capital Management opened 46 new positions and closed 46 in Q1 2021.
  • Suvretta Capital Management's portfolio value fell 3.5% quarter-over-quarter to $6.76B.

Based on Suvretta Capital Management's 13F filing for Q1 2021, filed 17 May 2021.